08:00 , Dec 12, 2011 |  BC Week In Review  |  Clinical News

Architect 25-OH Vitamin D assay regulatory update

FDA approved Abbott's Architect 25-OH Vitamin D assay as an aid in assessing vitamin D sufficiency. The chemiluminescent microparticle immunoassay (CMIA) quantitatively determines 25-hydroxyvitamin D in human serum and plasma, and runs on the pharma's...